Pfizer Announces Additional Phase 2/3 Study Results Confirming Robust Efficacy of Novel COVID-19 Oral Antiviral Treatment Candidate in Reducing Risk of Hospitalization or Death - discu.eu

Reddit

Pfizer Announces Additional Phase 2/3 Study Results Confirming Robust Efficacy of Novel COVID-19 Oral Antiviral Treatment Candidate in Reducing Risk of Hospitalization or Death https://www.pfizer.com/news/press-release/press-release-detail/pfizer-announces-additional-phase-23-study-results 7 comments 14/12/2021 worldnews